CN103599259B - 一种具有降血糖作用的傣药提取物制备及其应用 - Google Patents
一种具有降血糖作用的傣药提取物制备及其应用 Download PDFInfo
- Publication number
- CN103599259B CN103599259B CN201310648711.5A CN201310648711A CN103599259B CN 103599259 B CN103599259 B CN 103599259B CN 201310648711 A CN201310648711 A CN 201310648711A CN 103599259 B CN103599259 B CN 103599259B
- Authority
- CN
- China
- Prior art keywords
- extract
- parts
- dai nationality
- medicament
- medicinal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000000284 extract Substances 0.000 title claims abstract description 71
- 239000003814 drug Substances 0.000 title claims abstract description 33
- 230000002218 hypoglycaemic effect Effects 0.000 title claims abstract description 8
- 238000002360 preparation method Methods 0.000 title abstract description 15
- 239000004744 fabric Substances 0.000 claims abstract description 10
- 238000000605 extraction Methods 0.000 claims abstract description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 42
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 12
- 239000000741 silica gel Substances 0.000 claims description 12
- 229910002027 silica gel Inorganic materials 0.000 claims description 12
- 229960001866 silicon dioxide Drugs 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 11
- 239000000463 material Substances 0.000 claims description 10
- 239000012141 concentrate Substances 0.000 claims description 9
- 239000000843 powder Substances 0.000 claims description 8
- 239000007788 liquid Substances 0.000 claims description 7
- 238000001291 vacuum drying Methods 0.000 claims description 5
- 238000010438 heat treatment Methods 0.000 claims description 4
- 239000000825 pharmaceutical preparation Substances 0.000 claims description 4
- 238000010992 reflux Methods 0.000 claims description 4
- 238000002137 ultrasound extraction Methods 0.000 claims description 3
- 238000007605 air drying Methods 0.000 claims description 2
- 239000002775 capsule Substances 0.000 claims description 2
- 238000002156 mixing Methods 0.000 claims description 2
- 239000002904 solvent Substances 0.000 claims description 2
- 239000000835 fiber Substances 0.000 claims 2
- 239000008187 granular material Substances 0.000 claims 1
- 235000013402 health food Nutrition 0.000 claims 1
- 238000007654 immersion Methods 0.000 claims 1
- 239000003826 tablet Substances 0.000 claims 1
- 235000009508 confectionery Nutrition 0.000 abstract description 9
- 230000036541 health Effects 0.000 abstract description 8
- 229940079593 drug Drugs 0.000 abstract description 7
- 206010002091 Anaesthesia Diseases 0.000 abstract description 4
- 230000037005 anaesthesia Effects 0.000 abstract description 4
- 239000008194 pharmaceutical composition Substances 0.000 abstract description 3
- 241001640408 Aspidopterys Species 0.000 abstract description 2
- 241000218996 Passiflora Species 0.000 abstract description 2
- 239000003472 antidiabetic agent Substances 0.000 abstract description 2
- 241000723363 Clerodendrum Species 0.000 abstract 1
- 241001655694 Dischidia Species 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 22
- 239000008280 blood Substances 0.000 description 10
- 210000004369 blood Anatomy 0.000 description 10
- 238000003304 gavage Methods 0.000 description 10
- 240000007612 Dischidia nummularia Species 0.000 description 8
- 241001571504 Aspidopterys obcordata Species 0.000 description 7
- 241000410368 Clerodendrum japonicum Species 0.000 description 7
- 241000401681 Passiflora wilsonii Species 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 206010012601 diabetes mellitus Diseases 0.000 description 4
- 238000010790 dilution Methods 0.000 description 4
- 239000012895 dilution Substances 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 239000003480 eluent Substances 0.000 description 4
- 239000000499 gel Substances 0.000 description 4
- 238000000227 grinding Methods 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 238000010298 pulverizing process Methods 0.000 description 4
- 238000001179 sorption measurement Methods 0.000 description 4
- 230000003068 static effect Effects 0.000 description 4
- 239000000203 mixture Substances 0.000 description 3
- 230000036407 pain Effects 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 229920002527 Glycogen Polymers 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 229940096919 glycogen Drugs 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 201000001421 hyperglycemia Diseases 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 210000003127 knee Anatomy 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 206010036067 polydipsia Diseases 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 241000208327 Apocynaceae Species 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 241000345998 Calamus manan Species 0.000 description 1
- 206010013789 Dry throat Diseases 0.000 description 1
- 206010013911 Dysgeusia Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000002705 Glucose Intolerance Diseases 0.000 description 1
- 206010019851 Hepatotoxicity Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 206010022489 Insulin Resistance Diseases 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 241000208949 Malpighiaceae Species 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 208000005647 Mumps Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 235000011925 Passiflora alata Nutrition 0.000 description 1
- 235000000370 Passiflora edulis Nutrition 0.000 description 1
- 235000011922 Passiflora incarnata Nutrition 0.000 description 1
- 235000013750 Passiflora mixta Nutrition 0.000 description 1
- 235000013731 Passiflora van volxemii Nutrition 0.000 description 1
- 240000002834 Paulownia tomentosa Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000000254 damaging effect Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 230000007686 hepatotoxicity Effects 0.000 description 1
- 231100000304 hepatotoxicity Toxicity 0.000 description 1
- 230000003345 hyperglycaemic effect Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 210000004153 islets of langerhan Anatomy 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 229960001375 lactose Drugs 0.000 description 1
- 210000001165 lymph node Anatomy 0.000 description 1
- 235000001055 magnesium Nutrition 0.000 description 1
- 210000005075 mammary gland Anatomy 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 208000010805 mumps infectious disease Diseases 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 235000013809 polyvinylpolypyrrolidone Nutrition 0.000 description 1
- 229920000523 polyvinylpolypyrrolidone Polymers 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 201000009104 prediabetes syndrome Diseases 0.000 description 1
- -1 preferablyTablet Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 208000037821 progressive disease Diseases 0.000 description 1
- 235000012950 rattan cane Nutrition 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 229940083542 sodium Drugs 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 1
- 229940038773 trisodium citrate Drugs 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Description
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310648711.5A CN103599259B (zh) | 2013-12-06 | 2013-12-06 | 一种具有降血糖作用的傣药提取物制备及其应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310648711.5A CN103599259B (zh) | 2013-12-06 | 2013-12-06 | 一种具有降血糖作用的傣药提取物制备及其应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103599259A CN103599259A (zh) | 2014-02-26 |
CN103599259B true CN103599259B (zh) | 2016-05-11 |
Family
ID=50117565
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310648711.5A Expired - Fee Related CN103599259B (zh) | 2013-12-06 | 2013-12-06 | 一种具有降血糖作用的傣药提取物制备及其应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103599259B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104784377B (zh) * | 2015-04-24 | 2018-12-25 | 张宁 | 一种用于预防和治疗阿尔茨海默病的傣药复方提取物及其应用 |
CN108542927B (zh) * | 2018-05-25 | 2021-12-14 | 中国医学科学院药用植物研究所云南分所 | 倒心盾翅藤及其提取物在抗肿瘤方面的应用 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102178860A (zh) * | 2011-04-11 | 2011-09-14 | 赵龙山 | 一种治疗糖尿病的中药液 |
-
2013
- 2013-12-06 CN CN201310648711.5A patent/CN103599259B/zh not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102178860A (zh) * | 2011-04-11 | 2011-09-14 | 赵龙山 | 一种治疗糖尿病的中药液 |
Non-Patent Citations (2)
Title |
---|
8种傣药提取物体外抑制α-糖苷酶活性的研究;胡鑫等;《中南民族大学学报(自然科学版)》;20130930;第32卷(第3期);第60-62页及第117页 * |
西双版纳布朗族民间复方录;彭朝忠等;《中国民族民间医药杂志》;20070228(第1期,总第84期);第58页 * |
Also Published As
Publication number | Publication date |
---|---|
CN103599259A (zh) | 2014-02-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103285231A (zh) | 一种用于糖尿病辅助治疗的药物组合物及其制法 | |
CN101172125A (zh) | 灵芝液体发酵物、含该发酵物的组合物及制备方法和用途 | |
CN108186803A (zh) | 复方红衣补血口服液的制备工艺 | |
CN105708970B (zh) | 一种具有降血糖功能的保健食品 | |
CN104857154A (zh) | 一种治疗“三高”症的中药组合物及其制备方法 | |
CN103599259B (zh) | 一种具有降血糖作用的傣药提取物制备及其应用 | |
CN102847061B (zh) | 一种治疗小儿病毒性心肌炎的中药制剂及其制备方法 | |
CN104083640A (zh) | 一种治疗糖尿病的中药组合物及其制备方法 | |
CN103463177A (zh) | 一种改善和提高机体免疫力的中药保健品 | |
CN106361983A (zh) | 一种辅助治疗糖尿病的胶囊剂及其制备方法 | |
CN104225295B (zh) | 用于改善睡眠的组合物及其制备方法和应用 | |
CN102784230B (zh) | 一种治疗营养性贫血的药物组合物制剂 | |
CN102309705B (zh) | 一种降低血尿酸的药物及其制备方法和用途 | |
CN104548049A (zh) | 一种治疗老年性骨质疏松症的中药组合物及其制备方法 | |
CN104256618B (zh) | 一种降血糖的食品、保健品或药物组合物 | |
CN102949681B (zh) | 一种预防或治疗感冒的组合物及其制备方法 | |
CN105267711A (zh) | 一种用于治疗眩晕症的药物制剂 | |
CN101293059B (zh) | 一种治疗糖尿病的中药复方制剂 | |
CN103990018A (zh) | 一种抗糖尿病的中药制剂 | |
CN103202964A (zh) | 益脑安神药酒 | |
CN117959374B (zh) | 一种药食同源中药保健灸熏组合物的制备方法及其应用 | |
CN108478701A (zh) | 一种增强免疫力的含片 | |
CN106177176A (zh) | 一种保健品组合物及其制备方法和用途 | |
CN102579713B (zh) | 治疗儿童肥胖症的中药及制备方法 | |
CN100493576C (zh) | 治疗糖尿病眼并发症的中药制剂 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C53 | Correction of patent of invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Wang Zhigang Inventor after: Geng Fang Inventor after: Wang Fashan Inventor after: Zhang Ning Inventor after: Zhou Bo Inventor after: Dong Hui Inventor after: Shan Junna Inventor after: Xu Hongdan Inventor after: Li Bing Inventor after: Lei Shuangyuan Inventor after: Li Guang Inventor after: Yang Keke Inventor before: Wang Zhigang Inventor before: Zhou Bo Inventor before: Dong Hui Inventor before: Li Guang Inventor before: Xu Hongdan Inventor before: Yang Keke Inventor before: Pu Chengyu Inventor before: Wang Fashan Inventor before: Zhang Ning |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: WANG ZHIGANG ZHOU BO DONG HUI LI GUANG XU HONGDAN YANG KEKE PIAO CHENGYU WANG FASHAN ZHANG NING TO: WANG ZHIGANG ZHOU BO DONG HUI DAN JUNNA XU HONGDAN LI BING LEI SHUANGYUAN LI GUANG YANG KEKE GENG FANG WANG FASHAN ZHANG NING |
|
CB03 | Change of inventor or designer information |
Inventor after: Wang Zhigang Inventor after: Li Guang Inventor after: Zhao Dongxu Inventor after: Geng Fang Inventor after: Wang Fashan Inventor after: Zhang Ning Inventor after: Zhou Bo Inventor after: Dong Hui Inventor after: Wang Jiatian Inventor after: Qu Yan Inventor after: Liu Daxu Inventor after: Lei Shuangyuan Inventor after: Shan Junna Inventor after: Xu Hongdan Inventor before: Wang Zhigang Inventor before: Geng Fang Inventor before: Wang Fashan Inventor before: Zhang Ning Inventor before: Zhou Bo Inventor before: Dong Hui Inventor before: Shan Junna Inventor before: Xu Hongdan Inventor before: Li Bing Inventor before: Lei Shuangyuan Inventor before: Li Guang Inventor before: Yang Keke |
|
COR | Change of bibliographic data | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20160511 Termination date: 20211206 |